News Update: CPAP device approved for apnea in children
January 1, 2010
FDA has approved InnoMed's Nasal-Aire II Petite for continuous positive airway pressure (CPAP) therapy for the treatment of obstructive sleep apnea in children aged older than 7 years or weighing more than 40 lbs.
FDA has approved InnoMed's Nasal-Aire II Petite for continuous positive airway pressure (CPAP) therapy for the treatment of obstructive sleep apnea in children aged older than 7 years or weighing more than 40 lbs. This product is the first to use a nasal prong/nasal cannula/nasal pillow design rather than the traditional over-the-nose mask, a change that is intended to lead to greater patient compliance.
This device was also approved to provide positive pressure-based noninvasive ventilation for pediatric patients in both acute care and home settings.
